Migraine sufferers have a new ally in their fight against debilitating headaches. Anti-CGRP monoclonal antibodies are becoming a go-to choice for preventing migraines. These drugs work by targeting a specific pathway in the body involved in migraine attacks. But how well do patients stick with these
Migraines are a common and debilitating condition. Most people with migraines see their regular doctors for help. These doctors need to know about the latest treatments. One new type of medicine is called gepants. They target a specific protein involved in migraines. This makes them different from o
Chronic migraines are a real pain, literally. They can last for weeks or even months. People who suffer from them often try different treatments to find relief. One study looked at combining two treatments: atogepant and onabotulinumtoxinA. The goal was to see if this combo could help control chroni
Migraine sufferers often find relief with medications like valproate, topiramate, metoprolol, timolol, or propranolol. These are commonly prescribed as first-line treatments. But do these meds also lower the risk of ischemic stroke? That's what researchers wanted to find out. They dug into two mass
Meet rimegepant, a new drug that blocks certain signals in your brain to stop migraines. It's been tested in labs and found to work, but what about in the real world? That's what the GAINER study set out to find. This study, happening in multiple places, looked at how well rimegepant works and how t
